113
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Association between drug use and ART use among people living with HIV who inject drugs in Vietnam, Ukraine and Indonesia: results from HPTN 074

ORCID Icon, , , , ORCID Icon, , , , , , , & ORCID Icon show all
Pages 648-657 | Received 18 Mar 2021, Accepted 30 Sep 2021, Published online: 10 Jan 2022

References

  • Adedinsewo, D. A., Wei, S. C., Robertson, M., Rose, C., Johnson, C. H., Dombrowski, J., & Skarbinski, J. (2014). Timing of antiretroviral therapy initiation in a nationally representative sample of HIV-infected adults receiving medical care in the United States. AIDS Patient Care and STDs, 28(12), 613–621. https://doi.org/10.1089/apc.2014.0194
  • Azar, P., Wood, E., Nguyen, P., Luma, M., Montaner, J., Kerr, T., & Milloy, M. J. (2015). Drug use patterns associated with risk of non-adherence to antiretroviral therapy among HIV-positive illicit drug users in a Canadian setting: A longitudinal analysis. BMC Infectious Diseases, 15(1), 193. https://doi.org/10.1186/s12879-015-0913-0
  • Davis, A., McCrimmon, T., Dasgupta, A., Gilbert, L., Terlikbayeva, A., Hunt, T., Primbetova, S., Wu, E., Darisheva, M., & El-Bassel, N. (2018). Individual, social, and structural factors affecting antiretroviral therapy adherence among HIV-positive people who inject drugs in Kazakhstan. The International Journal on Drug Policy, 62, 43–50. https://doi.org/10.1016/j.drugpo.2018.08.014
  • Degenhardt, L., Peacock, A., Colledge, S., Leung, J., Grebely, J., Vickerman, P., Stone, J., Cunningham, E. B., Trickey, A., Dumchev, K., Lynskey, M., Griffiths, P., Mattick, R. P., Hickman, M., & Larney, S. (2017). Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: A multistage systematic review. The Lancet Global Health, 5(12), e1192–e1207. https://doi.org/10.1016/S2214-109X(17)30375-3
  • Fatseas, M., Lavie, E., Denis, C., & Auriacombe, M. (2009). Self-perceived motivation for benzodiazepine use and behavior related to benzodiazepine use among opiate-dependent patients. Journal of Substance Abuse Treatment, 37(4), 407–411. https://doi.org/10.1016/j.jsat.2009.03.006
  • Go, V. F., Hershow, R. B., Kiriazova, T., Sarasvita, R., Bui, Q., Latkin, C. A., Rose, S., Hamilton, E., Lancaster, K. E., Metzger, D., Hoffman, I. F., & Miller, W. C. (2019). Client and provider perspectives on antiretroviral treatment uptake and adherence among people who inject drugs in Indonesia, Ukraine and Vietnam: HPTN 074. AIDS and Behavior, 23(4), 1084–1093. https://doi.org/10.1007/s10461-018-2307-y
  • Gonzalez, A., Mimiaga, M. J., Israel, J., Andres Bedoya, C., & Safren, S. A. (2013). Substance use predictors of poor medication adherence: The role of substance use coping among HIV-infected patients in opioid dependence treatment. AIDS and Behavior, 17(1), 168–173. https://doi.org/10.1007/s10461-012-0319-6
  • Health, A. (2018). Assessment of HIV services packages for key populations in Indonesia. Washington, DC: APMG Health.
  • Hicks, P. L., Mulvey, K. P., Chander, G., Fleishman, J. A., Josephs, J. S., Korthuis, P. T., Hellinger, J., Gaist, P., Gebo, K. A., & Network, H. I. V. R. (2007). The impact of illicit drug use and substance abuse treatment on adherence to HAART. AIDS Care, 19(9), 1134–1140. https://doi.org/10.1080/09540120701351888
  • Kalichman, S. C., Catz, S., & Ramachandran, B. (1999). Barriers to HIV/AIDS treatment and treatment adherence among African-American adults with disadvantaged education. Journal of the National Medical Association, 91(8), 439–446.
  • Kerr, T., Marshall, B. D. L., Milloy, M. J., Zhang, R., Guillemi, S., Montaner, J. S. G., & Wood, E. (2012). Patterns of heroin and cocaine injection and plasma HIV-1 RNA suppression among a long-term cohort of injection drug users. Drug and Alcohol Dependence, 124(1–2), 108–112. https://doi.org/10.1016/j.drugalcdep.2011.12.019
  • Kuchinad, K. E., Hutton, H. E., Monroe, A. K., Anderson, G., Moore, R. D., & Chander, G. (2016). A qualitative study of barriers to and facilitators of optimal engagement in care among PLWH and substance use/misuse. BMC Research Notes, 9(1), 229. https://doi.org/10.1186/s13104-016-2032-4
  • Lancaster, K. E., Hoffman, I. F., Hanscom, B., Ha, T. V., Dumchev, K., Susami, H., Rose, S., Go, V. F., Reifeis, S. A., Mollan, K. R., Hudgens, M. G., Piwowar-Manning, E. M., Richardson, P., Dvoriak, S., Djoerban, Z., Kiriazova, T., Zeziulin, O., Djauzi, S., Ahn, C. V., Latkin, C., … Team, H. S. (2018). Regional differences between people who inject drugs in an HIV prevention trial integrating treatment and prevention (HPTN 074): A baseline analysis. Journal of the International AIDS Society, 21(10), e25195. https://doi.org/10.1002/jia2.25195
  • Latkin, C., Zelaya, C., Lancaster, K., & Tobin, K. (2017). Intervention manual - A research guide for counselors and system navigators conducting the intervention for HIV prevention trials Network 074. https://www.hptn.org/sites/default/files/inline-files/HPTN074SSPAppA_Intervention%20Manual_28Sep2017_V2.3.pdf
  • Lucas, G. M. (2011). Substance abuse, adherence with antiretroviral therapy, and clinical outcomes among HIV-infected individuals. Life Sciences, 88(21–22), 948–952. https://doi.org/10.1016/j.lfs.2010.09.025
  • Mathers, B. M., Degenhardt, L., Phillips, B., Wiessing, L., Hickman, M., Strathdee, S. A., Wodak, A., Panda, S., Tyndall, M., Toufik, A., & Mattick, R. P. (2008). Global epidemiology of injecting drug use and HIV among people who inject drugs: A systematic review. The Lancet, 372(9651), 1733–1745. https://doi.org/10.1016/S0140-6736(08)61311-2
  • Miller, W. C., Hoffman, I. F., Hanscom, B. S., Ha, T. V., Dumchev, K., Djoerban, Z., Rose, S. M., Latkin, C. A., Metzger, D. S., Lancaster, K. E., Go, V. F., Dvoriak, S., Mollan, K. R., Reifeis, S. A., Piwowar-Manning, E. M., Richardson, P., Hudgens, M. G., Hamilton, E. L., Sugarman, J., Eshleman, S. H., … Burns, D. N. (2018). A scalable, integrated intervention to engage people who inject drugs in HIV care and medication-assisted treatment (HPTN 074): A randomised, controlled phase 3 feasibility and efficacy study. The Lancet, 392(10149), 747–759. https://doi.org/10.1016/s0140-6736(18)31487-9
  • Moore, D. J., Blackstone, K., Woods, S. P., Ellis, R. J., Atkinson, J. H., Heaton, R. K., & Grant, I. (2012). Methamphetamine use and neuropsychiatric factors are associated with antiretroviral non-adherence. AIDS Care, 24(12), 1504–1513. https://doi.org/10.1080/09540121.2012.672718
  • Moses, T. E. H., & Greenwald, M. K. (2019). History of regular nonmedical sedative and/or alcohol use differentiates substance-use patterns and consequences among chronic heroin users. Addictive Behaviors, 97, 14–19. https://doi.org/10.1016/j.addbeh.2019.05.017
  • Rosen, M. I., Black, A. C., Arnsten, J. H., Simoni, J. M., Wagner, G. J., Goggin, K., Remien, R. H., Golin, C. E., Wang, Y., Bangsberg, D., & Liu, H. H. (2012). ART adherence changes among patients in community substance use treatment: A preliminary analysis from MACH14. AIDS Research and Therapy, 9(1), 30. https://doi.org/10.1186/1742-6405-9-30
  • Shah, R. Z., & McCann, K. (2011). 54 - Substance abuse and child abuse. In C. Jenny (Ed.), Child abuse and neglect (pp. 529–538). W.B. Saunders. https://doi.org/10.1016/B978-1-4160-6393-3.00053-1
  • Stein, M. D., Rich, J. D., Maksad, J., Chen, M. H., Hu, P., Sobota, M., & Clarke, J. (2000). Adherence to antiretroviral therapy among HIV-infected methadone patients: Effect of ongoing illicit drug use. The American Journal of Drug and Alcohol Abuse, 26(2), 195–205. https://doi.org/10.1081/ADA-100100600
  • Stimmel, B., & Kreek, M. J. (2000). Neurobiology of addictive behaviors and its relationship to methadone maintenance. The Mount Sinai Journal of Medicine, New York, 67(5–6), 375–380.
  • UNAIDS. (2018). Miles to go: Closing gaps breaking barriers righting injustices. UNAIDS.
  • UNAIDS. (2019). HIV and AIDS estimates. Country Factsheets Vietnam. https://www.unaids.org/en/regionscountries/countries/vietnam
  • Vourli, G., Nikolopoulos, G., Paparizos, V., Skoutelis, A., Metallidis, S., Gargalianos, P., Papadopoulos, A., Chini, M., Sipsas, N. V., Psychogiou, M., Chrysos, G., Sambatakou, H., Gogos, C., Katsarou, O., Paraskeva, D., Dedes, N., Touloumi, G., & Greek, H. I. V. P. G. (2018). HIV cascade of care in Greece: Useful insights from additional stages. PLoS One, 13(11), e0207355. https://doi.org/10.1371/journal.pone.0207355
  • Waller, D. G. (2018). Medical pharmacology and therapeutics E-Book. Substance Abuse and Dependence, 685.
  • Wolfe, D., Carrieri, M. P., & Shepard, D. (2010). Treatment and care for injecting drug users with HIV infection: A review of barriers and ways forward. The Lancet, 376(9738), 355–366. https://doi.org/10.1016/S0140-6736(10)60832-X

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.